| 1. | christiekeeton | |
| 2. | chaossue | |
| 3. | dodger1193 | |
| 4. | edsedw9emyj5jc7 | |
| 5. | lbrfella |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | dodger1193 01/18/2018 Paratek Announces Pricing of Public Offering of Common Stock |
| 2. | chaossue 01/18/2018 Down 10% so far and going lower, better when they do offerings on the way up rather than the way down |
| 3. | chaossue 01/19/2018 Paratek Announces Pricing of Public Offering of Common Stock |
| 4. | edsedw9emyj5jc7 06/07/2018 Paratek Demonstrates Breadth of Omadacycline Clinical and Microbiological Data at ASM Microbe 2018 |
| 5. | christiekeeton 04/05/2018 Cantor Fitzgerald sets PT at $50 |
| 6. | christiekeeton 02/05/2018 Paratek Completes Submission of New Drug Applications to U.S. Food and Drug Administration for Oral and Intravenous Omadacycline for Pneumonia and Skin Infections |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Paratek Pharmaceuticals, Inc.
- PRTK
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.